Clinical Trial Matcher

NCT06751498

The Value of a Convolutional Neural Network-Based Renal Artery Perfusion Model in Predicting Renal Function After Partial Nephrectomy: A Prospective Study

Recruiting · Not specified · Shao Pengfei · registry updated 2025-04-17

Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.

The goal of this observational study is to develop a CNN-based machine module to predict postoperative fractional renal function in people who are proposed to undergo partial nephrectomy. The main question it aims to answer is: • Does this machine learning model accurately predict renal function after partial nephrectomy?

Inclusion

  • people with stage cT1 renal tumors confirmed by preoperative CT or MR
  • people who are proposed to undergoing partial nephrectomy
  • localized renal tumors without lymph node and distant metastases as defined by NCCN guidelines
  • ECOG score of 0 or 1
  • Life expectancy greater than 10 years

Exclusion

  • people with surgically unresectable lesions
  • people with Abnormal preoperative renal function, eGFR(estimated by CKD-EPI)\<90ml/min/1.73m2
  • people who receive preoperative molecular targeted therapy, immunotherapy, chemotherapy
  • people with any contraindications to surgery
  • people who convert to radical nephrectomy during surgery
  • people who receive molecular targeted therapy, immunotherapy or chemotherapy during the postoperative follow-up period

Open NCT06751498 on ClinicalTrials.govAll conditions